Literature DB >> 34200159

Potential Misdiagnosis between COVID-19 and Dengue Infection Using Rapid Serological Test.

Siti Qamariyah Khairunisa1, Ilham Harlan Amarullah1, Siti Churrotin1, Anisa Lailatul Fitria1, Mochammad Amin1, Maria Inge Lusida1,2, Soegeng Soegijanto1,3.   

Abstract

The coronavirus disease 2019 (COVID-19) pandemic that has a significant rapid transmission is an international public health concern. Several dengue-endemic countries reported similar clinical and laboratory features between COVID-19 and dengue in the early incubation period, and thus discerning the infection is difficult. As a dengue-endemic country, Indonesia also poses the same challenge during the COVID-19 outbreak. This current study analyzed the IgG and IgM profiles from COVID-19 patients by using a serological SARS-CoV-2 and dengue rapid test. In addition, 38 sera from healthy individuals (pre-COVID-19 date) were analyzed using a dengue rapid test. Among 120 samples, 4 samples indicated dengue IgG positive. However, IgM, NS1, and RT-PCR analyses showed negative results. Interestingly, regarding seropositivity of NS1 and DENV IgG from healthy individuals (pre COVID-19 infection), two samples were positive DENV IgG, while one of them was positive NS1. This suggested that in the dengue-endemic area, many people have already experienced dengue and have immunity against dengue virus. There is also the possibility of antibody cross-reactivity between COVID-19 and dengue infection. This also emphasizes the high demand for a rapid method with high sensitivity and specificity that can distinguish between SARS-CoV-2 and dengue.

Entities:  

Keywords:  COVID-19; Sars-Cov 2; cross-reactivity; dengue; rapid serological test

Year:  2021        PMID: 34200159     DOI: 10.3390/idr13020050

Source DB:  PubMed          Journal:  Infect Dis Rep        ISSN: 2036-7430


  3 in total

1.  Devastating dengue outbreak amidst COVID-19 pandemic in Bangladesh: an alarming situation.

Authors:  Mohammad Mehedi Hasan; Abdul Moiz Sahito; Muhammad Muzzamil; Parvathy Mohanan; Zarmina Islam; Md Masum Billah; Mohammod Johirul Islam; Mohammad Yasir Essar
Journal:  Trop Med Health       Date:  2022-01-25

2.  Addressing the COVID-19 pandemic challenges for operational adaptations of a cluster randomized controlled trial on dengue vector control in Malaysia.

Authors:  Mitra Saadatian-Elahi; Neal Alexander; Tim Möhlmann; Farah Diana Ariffin; Frederic Schmitt; Jason H Richardson; Muriel Rabilloud; Nurulhusna Ab Hamid
Journal:  BMC Public Health       Date:  2022-04-06       Impact factor: 3.295

3.  Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.

Authors:  Yi-Ling Cheng; Chiao-Hsuan Chao; Yen-Chung Lai; Kun-Han Hsieh; Jen-Ren Wang; Shu-Wen Wan; Hong-Jyun Huang; Yung-Chun Chuang; Woei-Jer Chuang; Trai-Ming Yeh
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.